MYC status as a determinant of synergistic response to Olaparib and Palbociclib in ovarian cancer.
EBioMedicine. 2019 May;43:225-237. doi: 10.1016/j.ebiom.2019.03.027. Epub 2019 Mar 18.
EBioMedicine. 2019.
PMID: 30898650
Free PMC article.